Trial Information

Summary: Adult & children with Focal Segemental Glomerulosclerosis are needed for research study.

UVa Health System, Department of Nephrology seeks adults and children with focal segmental glomerulosclerosis for a research study.

The purpose of the study is to compare the effectiveness of 2 experimental treatment regimens in treating focal segmental glomerulosclerosis. Subjects in both groups will be required to take an ACE inhibitor and low-dose prednisone. There will be a total of 18 visits that last about 2 hours each. Study-related procedures and medicines are provided at no cost to the participant. There will be no compensation for this study.

For more information contact Lisa Workman 434-924-1803 or email ljw8b@virginia.edu
HIC # 11188

Primary Investigator: Victoria Norwood, MD





www.healthsystem.virginia.edu/clinical_trials

Contact:

Lisa Workman B.A.
University of Virginia
School of Medicine
Nephrology, Pediatrics
Box 801352
Charlottesville, VA 22908
Telephone: 434-984-1803
Fax: --
Email:

Profile Page: University of Virginia, Charlottesville, VA

  

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: August 12, 2008 at 2:55:47 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA